In a filing, BridgeBio Pharma Inc revealed its Director Valantine Hannah unloaded Company’s shares for reported $0.17 million on Jun
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
BridgeBio Pharma Inc’s filing revealed that its Chief Executive Officer Kumar Neil unloaded Company’s shares for reported $2.5 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
BridgeBio Pharma Inc’s recently made public that its Chief Executive Officer Kumar Neil unloaded Company’s shares for reported $2.5 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or